Trivivac

Measles, Mumps, and Rubella vaccine (trivalent) · Queen Sirikit National Institute of Child Health

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trivivac, covering 2013-01-08 to 2013-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants [Phase 2, Phase 3]